Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated March 24, 2026, reports on transactions by a Person Discharging Managerial Responsibilities (PDMR) in accordance with the UK Market Abuse Regulation. Haleon Plc is a consumer health company focused on everyday health across six categories, including Oral Health, Pain Relief, and Respiratory Health.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details share transactions related to executive compensation.
Material Changes and Transactions
On March 23, 2026, Brian McNamara, Chief Executive Officer, executed the following transactions related to the vesting of awards from the 2023 Performance Share Plan and Deferred Annual Bonus Plan:
- Acquisition (Performance Share Plan): Received 1,497,695.24 ordinary shares at a price of Nil.
- Disposal (Tax Liability - Performance Share Plan): Sold 704,974.22 ordinary shares at £3.684419 per share on the London Stock Exchange to cover tax liabilities.
- Acquisition (Deferred Annual Bonus Plan): Received 133,733.56 ordinary shares at a price of Nil.
- Disposal (Tax Liability - Deferred Annual Bonus Plan): Sold 63,012.31 ordinary shares at £3.684419 per share on the London Stock Exchange to cover tax liabilities.
The vesting was conditional on continued employment and performance conditions for the period ended December 31, 2025. Awards are subject to malus and clawback provisions.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. It notes that performance targets and achievement levels are disclosed in the 2025 Annual Report and Form 20-F. The primary risk mentioned relates to the malus and clawback provisions applicable to the awards.
Key Facts for Investor Verification
- Verify the total net share increase for the CEO after tax withholdings (Net acquisition: 863,442.27 shares).
- Confirm the share price of £3.684419 used for tax disposals against the market price on March 23, 2026.
- Review the 2025 Annual Report and Form 20-F for details on the performance conditions satisfied for the 2023-2025 period.
- Note that this filing is a regulatory disclosure of insider transactions and does not reflect company-wide financial results.